Metabolic Research Group

The Metabolic Research Group (MRG) focuses on advancing computational methods to identify and validate novel drug targets for metabolic diseases. Our research profile centers on the development and application of machine learning approaches, combined with statistical modeling, to extract biological knowledge from complex datasets. A key expertise of the group is the integration of diverse multiOmics data—including genomics, transcriptomics, proteomics, metabolomics, and metagenomics—enabling a systems-level understanding of metabolic processes and disease mechanisms. Through this integrative and data-driven approach, we aim to contribute to precision medicine by supporting the discovery of innovative therapeutic strategies within the TARGETWISE project.

Co-funded by the European Union, 2027 National Development Plan

The TARGETWISE project is supported by the European Regional Development Fund project under grant agreement No 1.1.1.5./2/24/A/003